DeLorean Artificial Intelligence

United States
Monroeville, Alabama, United States, 33480

Company profile

DeLorean Artificial Intelligence company profile

DeLorean AI is an artificial intelligence product company with products in healthcare (Medical AI) & sales (Sales AI). Medical AI predicts disease onset, transition and next best action (NBA) to slow the progress of disease and get the patient better. Medical AI is the first AI in the world to be biologically validated as well as the first AI to be applied at scale to focus on patient health. Currently, Medical AI has processed 45M patients and touches ~50% of the renal patients in the USA. Medical AI on average saves $100PMPM. Sales AI has been developed for B2B and B2C and is deployed at Fortune 500 companies. Our business model is AI as a Service.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Postal code
33480
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$10.5M
Last funding
Series A / $7.5M / 2023-08-01
Last equity funding
Series A / $7.5M
Investors
2
Lead investors
1
Founders
1
Articles
5

Founders and investors

Founders

Severence MacLaughlin

Lead investors

Sopris Capital Associates

Investors

Pinta Capital PartnersSopris Capital Associates